journal article·2020-12

Crystal structure of hyoscyamine sulfate monohydrate, (C 17 H 24 NO 3 ) 2 (SO 4 )(H 2 O)

James A. Kaduk, Amy M. Gindhart, Thomas N. Blanton

Powder Diffraction· Volume 35· Issue 4
Publisher page

Abstract

The crystal structure of hyoscyamine sulfate monohydrate has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional techniques. Hyoscyamine sulfate monohydrate crystallizes in space group P 2 1 (#4) with a = 6.60196(2), b = 12.95496(3), c = 20.93090(8) Å, β = 94.8839(2)°, V = 1783.680(5) Å 3 , and Z = 2. Despite the traditional description as a dihydrate, hyoscyamine sulfate crystallizes as a monohydrate. The two independent hyoscyamine cations have different conformations, which have similar energies. One of the cations is close to the minimum-energy conformation. Each of the protonated nitrogen atoms in the cations acts as a donor to the sulfate anion. The hydroxyl group of one cation acts as a donor to the sulfate anion, while the hydroxyl group of the other cation acts as a donor to the water molecule. The water molecule acts as a donor to two different sulfate anions. The cations and anions are linked by complex chains of hydrogen bonds along the a -axis. The powder pattern has been submitted for inclusion in the Powder Diffraction File™ (PDF®).
Source: crossref · Quality: baseline

Research context

OpenAlex topics: X-ray Diffraction in Crystallography · Crystallography and molecular interactions · Polymer Synthesis and Characterization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (30)

Show source-provided references
1. 10.1107/S002188981301311310.1107/S0021889813013113 ↗
2. 10.1017/S088571561700028810.1017/S0885715617000288 ↗
3. 10.1107/S056774087200717410.1107/S0567740872007174 ↗
4. 2017
5. 10.1002/jcc.2315310.1002/jcc.23153 ↗
6. Bravais · 1866
7. 10.1017/S088571561900081210.1017/S0885715619000812 ↗
8. Gore, V. , Joshi, R. , Tripathi, A. K. , Jadhav, M. , and Bhandari, S. (2014). “Crystalline atropine sulfate,” International Patent Application WO 2014/102829.
9. 10.1063/1.296926010.1063/1.2969260 ↗
10. 10.1107/S002188981101462210.1107/S0021889811014622 ↗
11. 10.1186/1758-2946-3-3310.1186/1758-2946-3-33 ↗
12. Wavefunction, Inc. (2017). Spartan ‘16 Version 2.0.1, Wavefunction Inc., 18401 Von Karman Ave., Suite 370, Irvine, CA 92612.
13. 10.1017/S088571561400090610.1017/S0885715614000906 ↗
14. 10.1107/S002188980706790810.1107/S0021889807067908 ↗
15. 10.1016/S0099-5428(08)60603-610.1016/S0099-5428(08)60603-6 ↗
16. 10.1017/S088571561400051710.1017/S0885715614000517 ↗
17. 10.1021/ci049780b10.1021/ci049780b ↗
18. 10.1002/qua.2465810.1002/qua.24658 ↗
19. 10.1107/S090904950801843810.1107/S0909049508018438 ↗
20. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
21. 10.1107/S002188981300353110.1107/S0021889813003531 ↗
22. A new law of crystal morphology extending the law of Bravais
23. 10.1007/BF0054909610.1007/BF00549096 ↗
24. Etudes sur la loi de Bravais
25. Turner · 2017
26. 10.1134/S106377451707020310.1134/S1063774517070203 ↗
27. 10.1063/1.46788210.1063/1.467882 ↗
28. 10.1017/S088571561800082910.1017/S0885715618000829 ↗
29. 10.1107/S205252061800233010.1107/S2052520618002330 ↗
30. 10.1107/S205252061402290210.1107/S2052520614022902 ↗